相关实验视频
Updated: May 24, 2025

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
9.3K
坦波尔通过氧化应激调节和MAPK路径抑制缓解甲基酸诱导的骨毒性
Fariz Selimli1, Meryem Taş Reyhanioğlu1, Ahmet Can Haskan1
1Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Mustafa Kemal University, Hatay, Turkey.
Drug design, development and therapy
|March 6, 2025
概括
坦波尔是一种抗氧化剂,通过减少氧化应激和亡,可以防止美托雷克萨特 (MTX) 诱导的骨损伤. 这项研究表明,Tempol.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 甲索 (MTX) 治疗可能会导致骨毒性,通过氧化应激和中断改造损害骨健康.
- 了解MTX诱导的骨损伤机制对于制定保护策略至关重要.
研究的目的:
- 研究氧化物抗氧化剂Tempol对甲基 (MTX) 诱导的骨质毒性的保护作用.
- 评估Tempol对骨细胞样细胞中亡途径和氧化应激标记物的影响.
主要方法:
- 用MTX和Tempol治疗了MLO-Y4骨质细胞样细胞.
- 评估了亡媒介体 (caspase-3,Bax,Bcl-2) 和MAPK信号传导 (JNK,ERK) 的变化.
- 测量了氧化应激参数,包括总抗氧化状态 (TAS),总氧化状态 (TOS),超氧化脱酶 (SOD) 和谷氨过氧化酶 (GPx).
主要成果:
- MTX增加了亡 (增加了酶-3,Bax;减少了Bcl-2) 并激活了MAPK通路 (JNK,ERK).
- 坦波尔治疗逆转了MTX诱导的亡和MAPK激活.
- 坦波尔增强了抗氧化能力 (增加了TAS,SOD,GPx) 和减少了氧化应激 (减少了TOS).
结论:
- 坦波尔通过对抗氧化应激和亡,有效地减轻MTX诱导的骨毒性.
- 在MTX治疗期间,Tempol显示出作为辅助疗法的潜力,以保持骨健康.
- 需要进一步的研究来探索Tempol对化疗患者骨完整性的长期影响.
更多相关视频
相关概念视频
Phase II Reactions: Methylation Reactions
110
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
110
Electron Transport Chain: Complex I and II
10.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K

